
HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Research analysts at HC Wainwright cut their FY2026 earnings per share estimates for shares of HIVE Blockchain Technologies in a research report issued to clients and investors on Tuesday, February 17th. HC Wainwright analyst M. Colonnese now expects that the company will post earnings of ($0.74) per share for the year, down from their previous forecast of ($0.40). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at ($0.27) EPS, Q1 2027 earnings at ($0.21) EPS, Q2 2027 earnings at ($0.12) EPS, Q3 2027 earnings at ($0.04) EPS, Q4 2027 earnings at $0.00 EPS and FY2027 earnings at ($0.37) EPS.
Other analysts also recently issued reports about the stock. Keefe, Bruyette & Woods downgraded shares of HIVE Blockchain Technologies from a “moderate buy” rating to a “hold” rating in a report on Tuesday, January 27th. B. Riley Financial upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday, November 21st. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
- Gilder: Don’t Buy AI Stocks, Do This Instead
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
